# Telmisartan 80mg Non-responder Trial

> **NCT01222520** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 174 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan and amlodipine
- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT01222520
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-06
- **Final completion:** —
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222520, "Telmisartan 80mg Non-responder Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01222520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*